The Smart Money is Moving In
It’s common knowledge among experienced investors that the price of a company’s stock, at any one time, is imperfectly related to the company’s actual value.
Other factors that affect the price include estimates of the company’s future revenues, earnings profit...
Read More
Be Not Afraid
One year ago, soon after marijuana sales became legal in Canada, investors were throwing money at the sector, anxious to get a piece of the action. Today, the opposite is true—getting money for a cannabis business takes real work!
That was my takeaway...
Read More
Lots of Crosscurrents!
The good news is that yesterday the U.S. House of Representatives voted in favor of the SAFE Banking Act (the acronym stands for "Secure and Fair Enforcement"), which would shield banks and other financial institutions from being held liable for serving businesses...
Read More
Buying Opportunity
It’s been rather frustrating to see cannabis stocks falling day after day, week after week, while the companies’ quarterly reports (with the exception of Canopy Growth) continue to reveal that business is booming. But that’s how the market works.
First, cannabis stocks attracted slew...
Read More
Bad News Bears
The stock market in general is quite healthy, with the major indexes at or near their highs, and all Cabot’s market timing indicators positive.
But the cannabis sector is still weak.
Part of this weakness stems from the fact that cannabis was the sector...
Read More
Cooling Off
They say a picture is worth a thousand words. This picture of the Marijuana Index tells a story that be summed up in fourteen.
From January through March, marijuana stocks were hot.
Since then, they’ve been cooling off.
The reasons for the strength were From...
Read More
Cannabis News
Fundamentally, the fastest-growing industry in America continues its rapid evolution. Some analysts now estimate that marijuana will be an $80 billion business in few years, while CBD sales will hit $16 billion by 2025.
It’s hard to know. But one big step comes tomorrow the...
Read More
Analyzing Stocks
I didn’t go to business school; I was an English major. But the values learned in our household were firmly grounded in free market capitalism and investing. Sunday mornings, after going to church, we would stop at the local newsstand to buy and...
Read More
CBD Stocks Soar
I take a dose of CBD twice a day. I think it works. I sleep better and have less discomfort in my finger joints—early signs of arthritis. But I’m not sure that it’s working, because there have been no major medical on...
Read More
Strength and Rotation
Sometimes investing is easy; sometimes it’s difficult. 2019 has been a piece of cake, so far, especially for investors in marijuana stocks.
While the S&P 500 is up 11.1%, year-to-date, the Marijuana Index is up 40.0%, and our own Marijuana Portfolio is 44.4%....
Read More
A Great Start to 2019
The marijuana industry is booming, at least when measured by revenues. Of the 15 stocks in our Marijuana Portfolio, the average growth rate of revenue in the latest reported quarter was 251%. If you take out the outliers (14% Turning...
Read More
The End of a Big Year
If you were investing a couple of decades ago, at the height of the dot.com boom, you no doubt remember stocks like Pets.com, Earthlink.com, Homestore.com, E Greetings Network, Chinadotcom Corp, Juno Online, Women.com Networks, Rare Medium Group, Drkoop.com, Jeeves,...
Read More
Is the Correction Over? Part 2
The good news is that the cannabis industry in North America is booming. Legal recreational sales in Canada are very healthy, with the only problem being a supply shortage—which will be alleviated in the months ahead. And legal continues...
Read More
Is the Correction Over?
Last Tuesday, the day before the opening of the legal commercial market for marijuana in Canada, I sent you an update that said, in part, “I believe the odds are that this will mark an intermediate-term top for many of stocks...
Read More
Eleven years ago, Sears stock was at all-time highs, a $23 billion company. Now the company is bankrupt, and the stock is almost at zero. What happened?!
Read More
October 17 Approaches!
First, I want to welcome all my new readers to the first issue of Cabot Marijuana Investor, the successor to the quarterly report that was Cabot’s Ten Best Marijuana stocks. When I started that report back in August 2017, I was about...
Read More
Eighteen months ago, Papa John's stock was trading at all-time highs. Thanks to a series of embarrassing missteps by its namesake CEO, it's down 46% since.
Read More
Once a high riser, the IHE biotech ETF has been stuck in the mud for two years. But that doesn't mean you should tune out the biopharma industry as a whole.
Read More
It was a rough week for the retail sector, but that doesn’t mean retailers no longer make good investment opportunities. Many of them still offer healthy share price returns in addition to regular dividend growth. Later in this article, I’ll tell you about I..
Read More
Would you lend a friend $100 if he promised to pay you back $99 within a year?
Read More
